Alcon Inc. (LON: 0A0D)
London
· Delayed Price · Currency is GBP · Price in CHF
71.58
-0.19 (-0.26%)
Jul 22, 2022, 8:20 AM BST
Alcon Revenue
Alcon had revenue of $2.45B USD in the quarter ending September 30, 2024, with 5.37% growth. This brings the company's revenue in the last twelve months to $9.76B, up 5.25% year-over-year. In the year 2023, Alcon had annual revenue of $9.46B with 8.47% growth.
Revenue (ttm)
$9.76B
Revenue Growth
+5.25%
P/S Ratio
n/a
Revenue / Employee
$385.58K
Employees
25,315
Market Cap
35.80B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
Dec 31, 2019 | 7.51B | 355.00M | 4.96% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |